541096 — Bharat Parenterals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹9.18bn
- IN₹10.33bn
- IN₹3.45bn
Annual cashflow statement for Bharat Parenterals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 279 | 235 | 187 | -340 | -214 |
| Depreciation | |||||
| Non-Cash Items | -18.1 | 29.2 | 63.1 | 51.6 | 146 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -338 | -107 | -387 | -338 | 109 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -10.7 | 217 | -47.1 | -273 | 384 |
| Capital Expenditures | -390 | -916 | -1,043 | -291 | -399 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 323 | 138 | -4.82 | -1,083 | 493 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -66.3 | -778 | -1,048 | -1,374 | 93.2 |
| Financing Cash Flow Items | 34.7 | 286 | 25.8 | -129 | -123 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 94.2 | 606 | 1,104 | 1,564 | -470 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 17.2 | 44.4 | 9.38 | -82.7 | 6.37 |